Humana Profits Dip To $162 Million As Costs Rise From New Medicare Enrollees
Humana reported Q3 net income of $162M, down from $195M YoY, as Medicare Advantage costs rose. Revenue increased to $41.2B. The company raised its 2026 adjusted EPS guidance to at least $9.50. Humana added over 1M Medicare Advantage enrollees, noting new members have higher benefit ratios. The company also expanded its Medicaid coverage and CenterWell business.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance lift may trigger short‑term buying, while cost pressures could temper long‑term upside.
Market read
First report of Humana's earnings and guidance update; material for health‑care sector and broader market.
What to watch
Potential regulatory scrutiny on Medicare Advantage cost structures and competitive pricing pressure.
Background
Humana's Q3 results show revenue growth from Medicare Advantage enrollment but higher cost ratios, prompting a modest earnings beat and guidance raise.
Ticker impact
Humana reported Q3 net income of $162M and raised FY2026 EPS guidance to at least $9.50, up from $9.00.
likely upward pressure as investors price in higher EPS guidance
Guidance lift is a fresh, material development for a large‑cap insurer; markets typically react positively.
Market effects
Higher Medicare Advantage enrollment and cost pressures may affect other health insurers' benefit ratios.
U.S. health‑care sector could see modest upside on earnings‑beat sentiment.
Limited; primarily U.S. health‑care investors.
Counterpoint
Rising medical loss ratios could erode margins, making the guidance lift less sustainable.
Key entities
- companyHumana
U.S. health insurer (ticker HUM) reporting Q3 results.
